ELITE PHARMACEUTICALS INC /NV/ reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 526-550 of 753 matching filings.

Per page
25
Current page
22
4

PRIMARY DOCUMENT

Filing date
11 Mar 2013
Reporting date
07 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Mar 2013
Reporting date
07 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Mar 2013
Reporting date
07 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Mar 2013
Reporting date
07 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
06 Feb 2013
Reporting date
31 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jan 2013
Reporting date
22 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jan 2013
Reporting date
22 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jan 2013
Reporting date
22 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jan 2013
Reporting date
22 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jan 2013
Reporting date
22 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2013
Reporting date
18 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2013
Reporting date
18 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2013
Reporting date
11 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2013
Reporting date
11 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2013
Reporting date
11 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2013
Reporting date
11 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2013
Reporting date
11 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59693

SC 13G/A

Filing date
08 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
03 Jan 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2012
Reporting date
26 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2012
Reporting date
26 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2012
Reporting date
26 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2012
Reporting date
26 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2012
Reporting date
26 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .